OTHER DRUGS USED TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES 126
MARKET SIZE 126
TABLE 80 GLOBAL SALES OF OTHER DRUGS USED TO TREAT NON- ALCOHOLIC FATTY LIVER DISEASES, BY REGION, THROUGH 2014 ($ MILLIONS) 126
FIGURE 46 GLOBAL SALES OF OTHER DRUGS USED IN THE TREATMENT OF NON- ALCOHOLIC FATTY LIVER DISEASES, BY REGION, 2007-2014 ($ MILLIONS) 127
Chapter-12: PATENT ANALYSIS
CHAPTER 13: PATENT ANALYSIS 128
PATENTS BY YEAR 128
TABLE 81 TOTAL NUMBER OF PATENTS EACH YEAR, 2005-2009 129
FIGURE 47 TOTAL NUMBER OF PATENTS EACH YEAR, 2005-2009 129
PATENTS BY TYPE 129
TABLE 82 NUMBER OF PATENTS BY TYPE, 2005-2009 130
FIGURE 48 NUMBER OF PATENTS BY TYPE, 2005-2009 130
FIGURE 49 PATENTS, SHARE BY TYPE, 2005-2009 (%) 131
PATENTS BY COUNTRY 131
TABLE 83 TOTAL NUMBER OF PATENTS BY COUNTRY, 2005-2009 132
FIGURE 50 TOTAL NUMBER OF PATENTS BY COUNTRY, 2005-2009 132
PATENTS BY COMPANY 133
TABLE 84 NUMBER OF PATENTS BY COMPANY, 2005-2009 133
FIGURE 51 TOTAL NUMBER OF PATENTS BY COMPANY, 2005-2009 134
PATENTS BY ASSIGNEE 134
TABLE 85 NUMBER OF PATENTS BY ASSIGNEE, 2005-2009 135
FIGURE 52 NUMBER OF PATENTS BY ASSIGNEE, 2005-2009 135
Chapter-13: COMPANY PROFILES
ABBOTT LABORATORIES 136
ACTAVIS U.S. 136
ALKERMES, INC 137
ALNYLAM PHARMACEUTICALS 137
BARR PHARMACEUTICALS 138
BAYER SCHERING PHARMA AG 138
BIOTEST PHARMACEUTICALS CORPORATION 138
BRISTOL-MYERS SQUIBB 139
CANGENE CORPORATION 140
DEBIOPHARM GROUP 140
ELI LILLY & COMPANY 141
GALMED MEDICAL RESEARCH, LTD. 142
GILEAD SCIENCES, INC. 142
GLAXOSMITHKLINE PLC 143
HUMAN GENOME SCIENCES
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |